|
05 Feb 2008 |
FDA Gives Green Light to Lpath's ASONEP(TM) IND Submittal
|
|
05 Feb 2008 |
MedImmune Submits Biologics License Application to FDA for Motavizumab
|
|
04 Feb 2008 |
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
|
|
04 Feb 2008 |
Promising Phase 3 Data for Ustekinumab (Cnto 1275) in Long-Term Improvement of Chronic Plaque Psoriasis
|
|
02 Feb 2008 |
Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis
|
|
01 Feb 2008 |
New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis
|
|
01 Feb 2008 |
ImmunoGen, Inc. Earns Milestone with IND Filing for BIIB015
|
|
31 Jan 2008 |
Pooled Phase 3 Study of Nplate(TM) (Romiplostim) in Adult Patients with Chronic ITP Published in the Lancet
|
|
31 Jan 2008 |
TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
|
|
30 Jan 2008 |
Viventia Biotech To Explore Strategic Alternatives
|
|
29 Jan 2008 |
Abbott and Eisai Finalize License Agreement in Japan for Additional Indications for Adalimumab, The Only Fully Human Monoclonal anti-TNFalpha Antibody
|
|
28 Jan 2008 |
Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancer
|
|
28 Jan 2008 |
Abbott and Eisai Announce Changes in the Sales Scheme in Japan for Adalimumab, A Fully Human Monoclonal Anti-TNF-alpha Antibody
|
|
28 Jan 2008 |
Lpath Successfully Humanizes Breakthrough Anti-LPA Antibody, Lpathomab(TM)
|
|
28 Jan 2008 |
Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
|
|
25 Jan 2008 |
MabThera meets study primary endpoint in improving disease symptoms when used as first biologic therapy in patients with rheumatoid arthritis
|
|
25 Jan 2008 |
MabThera increases the time patients with the most common form of adult leukaemia live without their cancer progressing
|
|
25 Jan 2008 |
KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients
|
|
24 Jan 2008 |
Denosumab Osteoporosis Study Met Primary and All Secondary Bone Mineral Density Endpoints in a Head-to-Head Comparison with Weekly Alendronate (FOSAMAX(R))
|
|
22 Jan 2008 |
CytoFab(TM) phase 2 programme in severe sepsis commenced byAstraZeneca
|
|
22 Jan 2008 |
Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
|
|
18 Jan 2008 |
ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
|
|
16 Jan 2008 |
MorphoSys Discloses GM-CSF as Target of MOR103 Program
|
|
16 Jan 2008 |
New Study Reports Enbrel(R) (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents
|
|
15 Jan 2008 |
BioInvent and Genentech Initiate Phase I Clinical Trial for BI-204, a potential treatment for cardiovascular conditions associated with atherosclerosis
|
